(1)
Cork, M. J.; Lockshin , B.; Pinter , A. .; Chen , Z.; Shumel , B. .; Prescilla, R. . Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis Who Did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial. Acta Derm Venereol 2024, 104, adv13467.